Literature DB >> 16771573

Viral nanoparticles donning a paramagnetic coat: conjugation of MRI contrast agents to the MS2 capsid.

Elizabeth A Anderson1, Steven Isaacman, David S Peabody, Edwin Y Wang, James W Canary, Kent Kirshenbaum.   

Abstract

A nanoparticle magnetic resonance imaging (MRI) contrast agent was developed by conjugation of more than 500 gadolinium chelate groups onto a viral capsid. The high density of paramagnetic centers and slow tumbling rate of modified MS2 capsids provided enhanced T1 relaxivities up to 7200 mM-1s-1 per particle. A bimodal imaging agent was generated by sequential conjugation of fluorescein and Gd3+ chelate. These results illustrate the potential for engineering natural protein assemblies to address bionanotechnology applications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16771573     DOI: 10.1021/nl060378g

Source DB:  PubMed          Journal:  Nano Lett        ISSN: 1530-6984            Impact factor:   11.189


  58 in total

1.  Self-organized Mn2+-Block Copolymer Complexes and Their Use for In Vivo MR Imaging of Biological Processes.

Authors:  Nikorn Pothayee; Der-Yow Chen; Maria A Aronova; Chunqi Qian; Nadia Bouraoud; Stephen Dodd; Richard D Leapman; Alan P Koretsky
Journal:  J Mater Chem B       Date:  2014       Impact factor: 6.331

2.  RGD-conjugated human ferritin nanoparticles for imaging vascular inflammation and angiogenesis in experimental carotid and aortic disease.

Authors:  Toshiro Kitagawa; Hisanori Kosuge; Masaki Uchida; Monica M Dua; Yasunori Iida; Ronald L Dalman; Trevor Douglas; Michael V McConnell
Journal:  Mol Imaging Biol       Date:  2012-06       Impact factor: 3.488

3.  Human ferritin cages for imaging vascular macrophages.

Authors:  Masahiro Terashima; Masaki Uchida; Hisanori Kosuge; Philip S Tsao; Mark J Young; Steven M Conolly; Trevor Douglas; Michael V McConnell
Journal:  Biomaterials       Date:  2010-11-11       Impact factor: 12.479

Review 4.  Non-invasive genetic imaging for molecular and cell therapies of cancer.

Authors:  C Belmar; P-W So; G Vassaux; V Moleiro-Sanemeterio; P Martín-Duque
Journal:  Clin Transl Oncol       Date:  2007-11       Impact factor: 3.405

Review 5.  Design rules for nanomedical engineering: from physical virology to the applications of virus-based materials in medicine.

Authors:  Amy M Wen; Pooja H Rambhia; Roger H French; Nicole F Steinmetz
Journal:  J Biol Phys       Date:  2013-04-19       Impact factor: 1.365

Review 6.  Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.

Authors:  Aaron Joseph L Villaraza; Ambika Bumb; Martin W Brechbiel
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

7.  Rational design of protein-based MRI contrast agents.

Authors:  Jenny J Yang; Jianhua Yang; Lixia Wei; Omar Zurkiya; Wei Yang; Shunyi Li; Jin Zou; Yubin Zhou; Anna L Wilkins Maniccia; Hui Mao; Fuqiang Zhao; Russell Malchow; Shumin Zhao; Julian Johnson; Xiaoping Hu; Eirik Krogstad; Zhi-Ren Liu
Journal:  J Am Chem Soc       Date:  2008-06-25       Impact factor: 15.419

8.  Tobacco mosaic virus rods and spheres as supramolecular high-relaxivity MRI contrast agents.

Authors:  Michael A Bruckman; Stephen Hern; Kai Jiang; Chris A Flask; Xin Yu; Nicole F Steinmetz
Journal:  J Mater Chem B       Date:  2013-03-14       Impact factor: 6.331

9.  Gadolinium-conjugated TiO2-DNA oligonucleotide nanoconjugates show prolonged intracellular retention period and T1-weighted contrast enhancement in magnetic resonance images.

Authors:  Tatjana Paunesku; Tianyi Ke; Rohan Dharmakumar; Nicole Mascheri; Aiguo Wu; Barry Lai; Stefan Vogt; Jörg Maser; Kenneth Thurn; Barbara Szolc-Kowalska; Andrew Larson; Raymond C Bergan; Reed Omary; Debiao Li; Zheng-Rong Lu; Gayle E Woloschak
Journal:  Nanomedicine       Date:  2008-06-24       Impact factor: 5.307

Review 10.  Modified natural nanoparticles as contrast agents for medical imaging.

Authors:  David P Cormode; Peter A Jarzyna; Willem J M Mulder; Zahi A Fayad
Journal:  Adv Drug Deliv Rev       Date:  2009-11-06       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.